Palisade Bio Statistics
NASDAQ: PALIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.8399-0.0855 (-9.24%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Palisade Bio by the numbers
Palisade Bio has a market capitalization of $150.7 million based on 179.28M shares outstanding. Its trailing P/E ratio is 0.9. The stock trades 38.5% below its 50-day average and 53.5% below its 200-day average.
Average daily trading volume is 3.19M shares, or about $2.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PALI valuation vs. peer median
| Metric | PALI | Peer median | Difference |
|---|---|---|---|
| Market cap | $150.74M | $132.16M | +14% |
| Avg. volume | 3.19M | 1.09M | +192% |
Peer median across 8 companies: STRO, TARA, CGEN, CMPX, HUMA, IVVD, ENGN, IKT.
Valuation
- Market cap
- $150.74M
- P/E (TTM)
- 0.91
- EPS (TTM)
- $0.92
- Shares outstanding
- 179.28M
Price and trading
- Previous close
- 0.9254
- Open
- 0.9111
- Day range
- 0.8381 – 0.96
- 52-week range
- 0.8381 – 2.86
- 52-week change
- -60.57%
- Beta
- —
- Volume
- 3.19M
- Average volume
- 3.19M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 150.74M
- Pe
- 0.91
- Forward Pe
- -2.54
- Eps
- 0.92
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.86
- Week52 Low
- 0.84
- Avg Volume
- 3.19M
- Shares Outstanding
- 179.28M
- Ma50
- 1.37
- Ma200
- 1.81
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -70.63%
- Pct From52w Low
- 0.21%